Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RESIDENT’S CORNER
Case of drug-induced kidney stone from overuse of phenazopyridine
Department of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA
Address correspondence to Dr. Suraj Pursnani, Department
of Urology, Penn State Milton S. Hershey Medical Center,
Mail Code H055, 500 University Drive, PO Box 850, Hershey,
PA 17033-0850 USA
Canadian Journal of Urology 2024, 31(3), 11911-11913.
Download PDFAbstract
Drug-induced nephrolithiasis represents only 1%-2% of stone cases. Here we focus on drugs capable of crystallizing and forming stone, specifically phenazopyridine (Pyridium/Azo). This is a case of a patient who presented with a stone conglomerate in the right proximal ureter and underwent definitive treatment. Interestingly, the stone had a purple hue with FTIR spectroscopy showing stone composition of calcium oxalate (monohydrate and dihydrate) and a material resembling phenazopyridine. We retrospectively learned that she used multiple extended courses of phenazopyridine over 3 months.Keywords
Pyridium, nephrolithiasis, drug-induced nephrolithiasis, phenazopyridine
Cite This Article
APA Style
Pursnani, S., Streeper, N.M. (2024). Case of drug-induced kidney stone from overuse of phenazopyridine. Canadian Journal of Urology, 31(3), 11911–11913.
Vancouver Style
Pursnani S, Streeper NM. Case of drug-induced kidney stone from overuse of phenazopyridine. Can J Urology. 2024;31(3):11911–11913.
IEEE Style
S. Pursnani and N.M. Streeper, “Case of drug-induced kidney stone from overuse of phenazopyridine,” Can. J. Urology, vol. 31, no. 3, pp. 11911–11913, 2024.
Copyright © 2024 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
